We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+21.5%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.75B
AUM Growth
+$332M
Cap. Flow
-$28.9M
Cap. Flow %
-0.5%
Top 10 Hldgs %
51.71%
Holding
444
New
223
Increased
65
Reduced
45
Closed
77

Top Buys

Rank Stock Value
1
BNTX icon
BioNTech
BNTX
+$54.6M
2
KYTX icon
Kyverna Therapeutics
KYTX
+$40.8M
3
SGRY icon
Surgery Partners
SGRY
+$33.8M
4
LRMR icon
Larimar Therapeutics
LRMR
+$33.4M
5
ALHC icon
Alignment Healthcare
ALHC
+$30.6M

Top Sells

Rank Stock Value
1
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$62.6M
2
SWTX
SpringWorks Therapeutics
SWTX
+$60.2M
3
BAX icon
Baxter International
BAX
+$55M
4
VKTX icon
Viking Therapeutics
VKTX
+$36.3M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$28.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.87%
2 Industrials 0.71%
3 Technology 0.31%
4 Consumer Discretionary 0.26%
5 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TLSIW icon
226
TriSalus Life Sciences Warrant
TLSIW
$25.1M
$333K 0.01%
333,333
– –
MARA icon
227
Marathon Digital Holdings
MARA
$3.83B
$332K 0.01%
+14,719
New +$322K
LFMD icon
228
LifeMD
LFMD
$176M
$330K 0.01%
+32,085
New +$237K
SD icon
229
SandRidge Energy
SD
$503M
$329K 0.01%
+22,579
New +$305K
TRNO icon
230
Terreno Realty
TRNO
$7.58B
$329K 0.01%
4,954
+1,502
+44% +$94.2K
MWA icon
231
Mueller Water Products
MWA
$3.94B
$328K 0.01%
+20,395
New +$303K
MCY icon
232
Mercury Insurance
MCY
$6B
$323K 0.01%
+6,265
New +$276K
METC icon
233
Ramaco Resources Class A
METC
$629M
$320K 0.01%
19,642
-23,791
-55% -$422K
THRM icon
234
Gentherm
THRM
$1.32B
$320K 0.01%
+5,557
New +$289K
ANIP icon
235
ANI Pharmaceuticals
ANIP
$1.86B
$320K 0.01%
4,627
-1,720
-27% -$104K
CRI icon
236
Carter's
CRI
$1.43B
$317K 0.01%
+3,743
New +$297K
RDNT icon
237
RadNet
RDNT
$4.98B
$314K 0.01%
+6,462
New +$260K
IRTC icon
238
iRhythm Holdings
IRTC
$4.02B
$313K 0.01%
+2,702
New +$304K
SONO icon
239
Sonos
SONO
$2.09B
$313K 0.01%
+16,432
New +$291K
CASH icon
240
Pathward Financial
CASH
$1.88B
$312K 0.01%
+6,188
New +$314K
COLL icon
241
Collegium Pharmaceutical
COLL
$1.18B
$311K 0.01%
8,015
-652
-8% -$22.8K
SMPL icon
242
Simply Good Foods
SMPL
$907M
$311K 0.01%
9,141
-61
-0.7% -$2.25K
OHI icon
243
Omega Healthcare
OHI
$15.3B
$310K 0.01%
+9,788
New +$298K
MKSI icon
244
MKS Inc
MKSI
$17.4B
$309K 0.01%
+2,326
New +$270K
STT icon
245
State Street
STT
$48.4B
$307K 0.01%
+3,967
New +$294K
ARES icon
246
Ares Management
ARES
$28.1B
$306K 0.01%
+2,304
New +$294K
AEO icon
247
American Eagle Outfitters
AEO
$2.94B
$306K 0.01%
11,856
+43
+0.4% +$955
AIN icon
248
Albany International
AIN
$2.09B
$301K 0.01%
+3,224
New +$296K
ALGN icon
249
Align Technology
ALGN
$12.9B
$300K 0.01%
+915
New +$268K
VYGR icon
250
Voyager Therapeutics
VYGR
$181M
$298K 0.01%
32,005
+16,518
+107% +$139K
8 9
10
11 12

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q1 2024 Portfolio in Review

As of Q1 2024, Deerfield Management held 444 positions worth $5.75B, up 6.1% from $5.42B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Deerfield Management's Q1 2024 filing shows 223 new, 65 increased, 45 reduced and 77 closed positions. Its largest new stake was BioNTech: 569,574 shares worth $52.5M. The largest sale was RayzeBio, Inc. Common Stock, an estimated $62.6M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 78% a quarter earlier, followed by Industrials and Technology.

  • Deerfield Management's largest Q1 2024 buy was BioNTech: 569,574 shares worth $52.5M.
  • Deerfield Management added most to Surgery Partners in Q1 2024, an estimated $33.8M increase.
  • Deerfield Management's biggest Q1 2024 reduction was SpringWorks Therapeutics, cutting an estimated $60.2M.
  • Deerfield Management fully exited RayzeBio, Inc. Common Stock in Q1 2024, selling an estimated $62.6M.
  • Deerfield Management's ten largest holdings make up 52% of its $5.75B portfolio in Q1 2024.
  • Deerfield Management opened 223 new positions and closed 77 in Q1 2024.
  • Deerfield Management's portfolio value rose 6.1% quarter-over-quarter to $5.75B.

Based on Deerfield Management's 13F filing for Q1 2024, filed 15 May 2024.